150 results
Keyword Epinephrine Remove keyword
-
List item
Referral: Adrenaline auto-injectors
adrenaline (epinephrine), Article 31 referrals
Status: European Commission final decision, opinion/position date: 25/06/2015, EC decision date: 14/08/2015, Last updated: 26/08/2015al. (2013). "Predictors of epinephrine autoinjector needle length … randomized maternal evaluation of epinephrine autoinjection devices." Pediatr … E., X. Gu, et al. (2001). "Epinephrine absorption in adults: intramuscular … -
List item
Press release: Better training tools recommended to support patients using adrenaline auto-injectors
CHMP, Last updated: 26/06/2015al. (2013). "Predictors of epinephrine autoinjector needle length … randomized maternal evaluation of epinephrine autoinjection devices." Pediatr … E., X. Gu, et al. (2001). "Epinephrine absorption in adults: intramuscular … -
List item
National expert: Kai Knudsen, European Medicines Agency (updated)
- Declaration of interests - 79.77 KB | PDF
- Curriculum Vitae - 24.44 KB | PDF
2005;45:3294-9 15. Knudsen K. & Abrahamsson J. Epinephrine and sodium bicarbonate independently … Abrahamsson J. Effects of epinephrine, norepinephrine, magnesium … Abrahamsson J. Effects of epinephrine and norepinephrine on hemodynamic parameters … -
List item
National expert: Rolf Gedeborg, Medical Products Agency (updated)
- Declaration of interests - 79.86 KB | PDF
- Curriculum Vitae - 27.48 KB | PDF
-
List item
National expert: Nadine Petitpain, Ministry for Health (updated)
- Declaration of interests - 81.17 KB | PDF
- Curriculum Vitae - 26.22 KB | PDF
-
List item
Referral: Septanest and associated names
articaine (hydrochloride), adrenaline (tartrate), Article 30 referrals
Status: European Commission final decision, opinion/position date: 28/06/2018, EC decision date: 28/03/2019, Last updated: 19/06/2019together with adrenaline (epinephrine), which helps prolong articaine’s … -
List item
Human medicine European public assessment report (EPAR): Giapreza
Angiotensin II acetate, Hypotension, Shock
Date of authorisation: 23/08/2019,
, Revision: 1, Authorised, Last updated: 23/03/2021
-
List item
Human medicine European public assessment report (EPAR): Insulin aspart Sanofi (updated)
insulin aspart, Diabetes Mellitus
Date of authorisation: 25/06/2020,
, Revision: 2, Authorised, Last updated: 04/05/2021
-
List item
Human medicine European public assessment report (EPAR): Rapiscan (updated)
regadenoson, Myocardial Perfusion Imaging
Date of authorisation: 06/09/2010, Revision: 12, Authorised, Last updated: 30/04/2021 -
List item
Human medicine European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron) (updated)
dinutuximab beta, Neuroblastoma
Date of authorisation: 08/05/2017,, 
, 
, Revision: 9, Authorised, Last updated: 26/04/2021
-
List item
Human medicine European public assessment report (EPAR): Olanzapine Teva
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 12/12/2007,
, Revision: 28, Authorised, Last updated: 08/04/2021
-
List item
Human medicine European public assessment report (EPAR): Oncaspar (updated)
pegaspargase, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 14/01/2016, Revision: 13, Authorised, Last updated: 15/04/2021 -
List item
Human medicine European public assessment report (EPAR): Abasaglar (previously Abasria)
insulin glargine, Diabetes Mellitus
Date of authorisation: 09/09/2014,, Revision: 11, Authorised, Last updated: 22/03/2021
-
List item
Human medicine European public assessment report (EPAR): Ruxience (updated)
rituximab, Leukemia, Lymphocytic, Chronic, B-Cell, Arthritis, Rheumatoid, Microscopic Polyangiitis, Pemphigus
Date of authorisation: 01/04/2020,, , Revision: 3, Authorised, Last updated: 11/05/2021
-
List item
Human medicine European public assessment report (EPAR): Amglidia
glibenclamide, Diabetes Mellitus
Date of authorisation: 24/05/2018,, Revision: 4, Authorised, Last updated: 31/03/2021
-
List item
Human medicine European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos)
daunorubicin hydrochloride, cytarabine, Leukemia, Myeloid, Acute
Date of authorisation: 23/08/2018,, Revision: 5, Authorised, Last updated: 08/03/2021
should be given, and an epinephrine (adrenaline) or bronchodilators … -
List item
Human medicine European public assessment report (EPAR): Nuceiva
Botulinum toxin type A, Skin Aging
Date of authorisation: 27/09/2019,, Revision: 2, Authorised, Last updated: 19/02/2021
injection of botulinum toxin. Epinephrine (adrenaline) or any other … -
List item
Veterinary medicine European public assessment report (EPAR): SevoFlo
sevoflurane, Dogs, Cats
Date of authorisation: 11/12/2002, Revision: 18, Authorised, Last updated: 29/03/2021 -
List item
Human medicine European public assessment report (EPAR): Ganfort (updated)
bimatoprost, timolol, Glaucoma, Open-Angle, Ocular Hypertension
Date of authorisation: 19/05/2006, Revision: 20, Authorised, Last updated: 23/04/2021 -
List item
Human medicine European public assessment report (EPAR): Olanzapine Mylan
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 06/10/2008,, Revision: 16, Authorised, Last updated: 23/03/2021
-
List item
Human medicine European public assessment report (EPAR): Firazyr
icatibant, Angioedemas, Hereditary
Date of authorisation: 11/07/2008, Revision: 18, Authorised, Last updated: 01/12/2020 -
List item
Human medicine European public assessment report (EPAR): Naglazyme
galsulfase, Mucopolysaccharidosis VI
Date of authorisation: 23/01/2006,, , Revision: 18, Authorised, Last updated: 17/03/2021
-
List item
Human medicine European public assessment report (EPAR): Lantus
insulin glargine, Diabetes Mellitus
Date of authorisation: 09/06/2000, Revision: 36, Authorised, Last updated: 01/03/2021 -
List item
Human medicine European public assessment report (EPAR): Ledaga
Chlormethine, Mycosis Fungoides
Date of authorisation: 03/03/2017,, Revision: 6, Authorised, Last updated: 10/03/2021
-
List item
Human medicine European public assessment report (EPAR): Nexavar (updated)
sorafenib, Carcinoma, Hepatocellular, Carcinoma, Renal Cell
Date of authorisation: 19/07/2006,, Revision: 29, Authorised, Last updated: 12/05/2021